1. Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance
   Yue Zhang et al, 2020, Biomarker Research CrossRef
2. Development of Fused and Substituted Pyrimidine Derivatives as Potent Anticancer Agents (A Review)
   Nahid Abbas et al, 2021, Pharmaceutical Chemistry Journal CrossRef
3. Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers
   Parinaz Nasri Nasrabadi et al, 2020, PLOS ONE CrossRef
4. Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma
   Wen-Lung Su et al, 2020, Cancer Biomarkers CrossRef
5. AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription
   Jiling Wen et al, 2024, Heliyon CrossRef
6. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
   Alessio Stefani et al, 2022, Frontiers in Oncology CrossRef
7. Antiproliferative Activity of a New Quinazolin-4(3H)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer
   Ji Yun Lee et al, 2022, Pharmaceuticals CrossRef
8. AURORA KINASE A and related downstream molecules: A potential network for cancer therapy
   Homa Fatma et al, 2023, Regulation of Downstream Targets CrossRef
9. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development
   Rong Wei et al, 2020, BMC Medical Genomics CrossRef
10. ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance
    Dania Movia et al, 2019, BMC Cancer CrossRef
11. Combinatory use of distinct single-cell RNA-seq analytical platforms reveals the heterogeneous transcriptome response
    Yukie Kashima et al, 2018, Scientific Reports CrossRef
12. Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor
    Thu-Hien Tran et al, 2022, International Journal of Molecular Medicine CrossRef
13. A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids
    Daniela Rodrigues et al, 2022, International Journal of Molecular Sciences CrossRef
14. Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
    Sonali Kurup et al, 2018, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
15. Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
    Mengjie Guo et al, 2018, BMC Systems Biology CrossRef
16. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
    Khyati N. Shah et al, 2019, Nature Medicine CrossRef